Neuphoria Therapeutics In... (NEUP)
5.44
0.06 (1.12%)
At close: Mar 24, 2025, 3:59 PM
5.55
2.01%
After-hours: Mar 24, 2025, 07:50 PM EDT
1.12% (1D)
| Bid | 5.07 |
| Market Cap | 9.56M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | 10.93 |
| PE Ratio (ttm) | 0.5 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 5.64 |
| Volume | 26,736 |
| Avg. Volume (20D) | 616,837 |
| Open | 5.49 |
| Previous Close | 5.38 |
| Day's Range | 5.31 - 5.70 |
| 52-Week Range | 2.12 - 15.24 |
| Beta | 0.38 |
About NEUP
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA....
Industry Medical - Pharmaceuticals
Sector Healthcare
IPO Date Dec 16, 2021
Employees 8
Stock Exchange NASDAQ
Ticker Symbol NEUP
Website http://www.neuphoriatx.com
Analyst Forecast
According to 1 analyst ratings, the average rating for NEUP stock is "Strong Buy." The 12-month stock price forecast is $21, which is an increase of 286.03% from the latest price.
Stock Forecasts1 month ago
Neuphoria Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
